Buchumschlag

Association of benzodiazepine and Z‐hypnotic use with cardiovascular disease risk: insights from a prospective study of 10 million people in China

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Ruotong Yang, Huan Yu, Junhui Wu, Siyue Wang, Hongbo Chen, Mengying Wang, Xueying Qin, Tao Wu, Yiqun Wu, Yonghua Hu
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Psychiatry and Clinical Neurosciences
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Novel hypnotics use and hip fracture risk in middle‐aged and older adults: A large, population‐based cohort study in Japan
von: Nana Shibata, et al.
Veröffentlicht: (2025)

Higher discontinuation with dual orexin receptor antagonists than with benzodiazepines: A Japanese claims cohort study
von: Kazuhiro Kurihara, et al.
Veröffentlicht: (2025)

Dementia treatment and prevention in the era of 60 million patients: advancing disease‐modifying therapies faster, wider, and deeper
von: Masaru Mimura
Veröffentlicht: (2024)

Psychosocial characteristics of the general population who habitually use hypnotics: Results from a national survey on drug use among the Japanese
von: Satomi Mizuno, et al.
Veröffentlicht: (2024)

Glymphatic dysfunction as an indicator of disease burden and a potential biomarker in anti‐ NMDAR encephalitis
von: Han Cai, et al.
Veröffentlicht: (2025)

Failed prevention of benzodiazepine withdrawal symptoms due to spontaneous expulsion of diazepam suppository administrated via stoma: A case report
von: Yuto Yamada, et al.
Veröffentlicht: (2024)

The association between levels of brain‐derived neurotrophic factor and comorbid depression in patients with cardiovascular disease: The Framingham Heart Study
von: Sara Medved, et al.
Veröffentlicht: (2024)

Associations between attenuated auditory p300 event‐related potential and cognitive basic symptoms in young people at clinical high risk for psychosis
von: James C. Martin, et al.
Veröffentlicht: (2025)

Risk of post‐ COVID ‐19 mental and physical health outcomes among SARS ‐ CoV ‐2‐immunologically naïve people
von: Pao‐Huan Chen, et al.
Veröffentlicht: (2025)

Placebo versus no treatment for people with schizophrenia: A systematic review and meta‐analysis
von: Nobuyuki Nomura, et al.
Veröffentlicht: (2025)

Indicative biomarkers of Lewy body disease with oral sensory hallucinations in the older people
von: Hitomi Matsui, et al.
Veröffentlicht: (2024)

Unveiling causal relationships between inflammatory cytokines and neurite orientation dispersion and density imaging phenotypes: Insights from bidirectional Mendelian randomization and bibliometric analysis
von: Longtao Yang, et al.
Veröffentlicht: (2026)

Normative brain variability, clinical dimension, and molecular‐transcriptomic correlates of bipolar risk in depressed patients
von: Junneng Shao, et al.
Veröffentlicht: (2026)

Effects of particulate matter exposures on depressive symptom trajectories: Evidence from a national longitudinal survey in China
von: Hengchang Wang, et al.
Veröffentlicht: (2026)

Association between serum cytokines and timeframe for conversion from clinical high‐risk to psychosis
von: TianHong Zhang, et al.
Veröffentlicht: (2024)

Genetics of bipolar disorder: Translating discoveries to biological insights and clinical decision support
von: Guy Hindley, et al.
Veröffentlicht: (2026)

Development of disease‐modifying therapies against Alzheimer's disease
von: Takeshi Iwatsubo
Veröffentlicht: (2024)

Depression, antidepressant use, and breast cancer incidence: results from the E3N prospective cohort
von: Romain Colle, et al.
Veröffentlicht: (2025)

Altered cardiac timing neural avalanche in major depressive disorder: new insights from magnetoencephalography
von: Qian Liao, et al.
Veröffentlicht: (2025)

Digital phenotyping of social functioning and employment in people with schizophrenia: Pilot data from an international sample
von: Erlend Lane, et al.
Veröffentlicht: (2025)

Disturbing dreams and dementia risk across diverse populations
von: Abidemi I Otaiku
Veröffentlicht: (2026)

Unexpected risk factors of pathological hikikomori during the COVID‐19 pandemic among working adults initially without social isolation: A longitudinal online survey
von: Kuan‐Lun Huang, et al.
Veröffentlicht: (2024)

Fronto‐limbic emotional‐processing markers signal risk of onset rather than risk of recurrence in mood disorders: Evidence from a longitudinal twin study
von: Julian Macoveanu, et al.
Veröffentlicht: (2026)

Depressive symptoms and carotid arteriosclerosis in very old people aged 85 years and older: A cross‐sectional study by the Kawasaki Aging and Wellbeing Project
von: Ryo Shikimoto, et al.
Veröffentlicht: (2024)

Serum ergothioneine and risk of dementia in a general older Japanese population: the Hisayama Study
von: Xiangyin Meng, et al.
Veröffentlicht: (2025)

Congenital hypothyroidism and risk of subsequent autism spectrum disorder and attention‐deficit/hyperactivity disorder in Taiwan
von: Hung‐Yi Lin, et al.
Veröffentlicht: (2024)

Mendelian randomization analyses uncover causal relationships between brain structural connectome and risk of psychiatric disorders
von: Kanwei Xiao, et al.
Veröffentlicht: (2025)

Linking autism risk genes to morphological and pharmaceutical screening by high‐content imaging: Future directions and opinion
von: Reza K. Arta, et al.
Veröffentlicht: (2025)

The effects of potentially traumatic events on the recovery from pre‐existing anxiety and depression symptomatology and the risk of PTSD
von: Peter G. van der Velden, et al.
Veröffentlicht: (2024)

Is clozapine use a risk of hematological malignancies? Insights from a meta‐analysis “Clozapine and Malignancy Risk”
von: Omar Kassar, et al.
Veröffentlicht: (2025)

Field survey of support groups for people with neurodevelopmental disorders in Japan
von: Sayo Hamatani, et al.
Veröffentlicht: (2024)

Flunitrazepam increases the risk of lamotrigine‐induced cutaneous adverse reactions: Combined analysis of medical big data and clinical research
von: Hiroshi Bando, et al.
Veröffentlicht: (2025)

Response to [Comment on is clozapine use a risk of hematological malignancies? Insights from a meta‐analysis “Clozapine and Malignancy Risk”]
von: Omar Kassar, et al.
Veröffentlicht: (2025)

Arginine vasopressin in mood disorders: A potential biomarker of disease pathology and a target for pharmacologic intervention
von: Hiroe Hu, et al.
Veröffentlicht: (2024)

Psychiatric‐onset neuronal intranuclear inclusion disease in a psychiatry‐based dementia‐enriched cohort in Japan
von: Tesshin Miyamoto, et al.
Veröffentlicht: (2025)

Risk of subsequent Parkinson's disease among patients with bipolar disorder or major depression: A nationwide longitudinal study in Taiwan
von: Mao‐Hsuan Huang, et al.
Veröffentlicht: (2024)

Mapping the landscape of mental health research through Google Trends: Bibliometric and thematic insights
von: Abhishek Ghosh, et al.
Veröffentlicht: (2025)

Frailty subtypes and white matter alterations in older adults without dementia
von: Chen‐Hua Lin, et al.
Veröffentlicht: (2025)

Improvement in avoidance in major depressive disorder: A 10‐month prospective study of depressive symptoms and personality traits
von: Ryotaro Higuchi, et al.
Veröffentlicht: (2026)

What transgender individuals in Japan expect from gender‐affirming surgery: A multicenter prospective observational study
von: Wakako Yorozuya, et al.
Veröffentlicht: (2025)